Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Andrew Chambers

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Pharmacology, Biochemistry, and Behavior|April 30, 2011
Nicotine exposure during adolescence enhances behavioral sensitivity to nicotine during adulthood in Wistar ratsAmy L Bracken, R Andrew Chambers, Sarah A Berg, et al.
Addiction Biology|August 8, 2013
Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesionsSarah A Berg, Alena M Sentir, Benjamin S Cooley, et al.
Drug and Alcohol Dependence|April 1, 2014
The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuseEric R Wright, Harold E Kooreman, Marion S Greene, et al.
Journal of Studies on Alcohol and Drugs|February 16, 2012
Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedureMarc I Kruse, Alexander J Radnovich, Raj K Kalapatapu, et al.
The American Journal on Addictions|September 21, 2016
Prescription drug monitoring program data tracking of opioid addiction treatment outcomes in integrated dual diagnosis care involving injectable naltrexoneAyesha Sajid, Aaron Whiteman, Richard L Bell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 31, 2014
Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophreniaChristopher C Lapish, Kee-Chan Ahn, R Andrew Chambers, et al.
The International Journal of Neuropsychopharmacology|July 25, 2009
GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophreniaJenifer L Vohs, R Andrew Chambers, Giri P Krishnan, et al.
The American Journal on Addictions|February 8, 2025
Adverse childhood experiences, insecure attachment, and appointment compliance in an outpatient addiction psychiatry treatment populationJoanna E Chambers, Susan M Perkins, Kelly M Mosesso, et al.
Neural Regeneration Research|November 26, 2014
Transcranial magnetic stimulation: potential treatment for co-occurring alcohol, traumatic brain injury and posttraumatic stress disordersAmy A Herrold, Sandra L Kletzel, Brett C Harton, et al.
Brain Imaging and Behavior|March 9, 2017
Global white matter microstructural abnormalities associated with addiction liability score in drug naïve youthLeslie Hulvershorn, Tom Hummer, Yu-Chien Wu, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Pharmacology, Biochemistry, and Behavior|April 30, 2011
Nicotine exposure during adolescence enhances behavioral sensitivity to nicotine during adulthood in Wistar ratsAmy L Bracken, R Andrew Chambers, Sarah A Berg, et al.
Addiction Biology|August 8, 2013
Nicotine is more addictive, not more cognitively therapeutic in a neurodevelopmental model of schizophrenia produced by neonatal ventral hippocampal lesionsSarah A Berg, Alena M Sentir, Benjamin S Cooley, et al.
Drug and Alcohol Dependence|April 1, 2014
The iatrogenic epidemic of prescription drug abuse: county-level determinants of opioid availability and abuseEric R Wright, Harold E Kooreman, Marion S Greene, et al.
Journal of Studies on Alcohol and Drugs|February 16, 2012
Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedureMarc I Kruse, Alexander J Radnovich, Raj K Kalapatapu, et al.
The American Journal on Addictions|September 21, 2016
Prescription drug monitoring program data tracking of opioid addiction treatment outcomes in integrated dual diagnosis care involving injectable naltrexoneAyesha Sajid, Aaron Whiteman, Richard L Bell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 31, 2014
Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophreniaChristopher C Lapish, Kee-Chan Ahn, R Andrew Chambers, et al.
The International Journal of Neuropsychopharmacology|July 25, 2009
GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophreniaJenifer L Vohs, R Andrew Chambers, Giri P Krishnan, et al.
The American Journal on Addictions|February 8, 2025
Adverse childhood experiences, insecure attachment, and appointment compliance in an outpatient addiction psychiatry treatment populationJoanna E Chambers, Susan M Perkins, Kelly M Mosesso, et al.
Neural Regeneration Research|November 26, 2014
Transcranial magnetic stimulation: potential treatment for co-occurring alcohol, traumatic brain injury and posttraumatic stress disordersAmy A Herrold, Sandra L Kletzel, Brett C Harton, et al.
Brain Imaging and Behavior|March 9, 2017
Global white matter microstructural abnormalities associated with addiction liability score in drug naïve youthLeslie Hulvershorn, Tom Hummer, Yu-Chien Wu, et al.
Pageof 5